Precision biosciences inc stock.

Yu: Precision BioSciences: Current Employment, Current equity holder in publicly-traded company. Heery: Precision BioSciences: Current equity holder in publicly-traded company, Ended employment in the past 24 months; Arcellx: Current Employment, Current holder of stock options in a privately-held company.

Precision biosciences inc stock. Things To Know About Precision biosciences inc stock.

Jun 30, 2022 · In June 2022, Precision announced the closing of an underwritten offering of 35,971,224 shares of its common stock at an offering price of $1.39 per share, for total net proceeds of approximately $46.7 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. If you are looking for stocks with good return, Precision Biosciences Inc stock can be a bad, high-risk 1-year investment option. Precision Biosciences Inc real time quote is equal to 0.363 USD at 2023-12-03, but your current investment may be devalued in the future. ...WebDURHAM, N.C., August 15, 2023--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based in vivo gene editing therapies, today announced completion ...Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for DTIL stock stock is $3.00, which predicts an increase of ...

Precision BioSciences, Inc. Stock price BOERSE MUENCHEN Equities PBS US74019P1084 Biotechnology & Medical Research Real-time BOERSE MUENCHEN. Other stock markets. 09:13:47 2023-11-21 am EST 5-day change 1st Jan Change ...

DTIL | Complete Precision Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.On Friday, Precision Biosciences Inc [NASDAQ:DTIL] saw its stock fall -5.64% to $0.40. On the same session, the stock had its day’s lowest price of $0.3853, but rose to a high of $0.44. Over the last five days, the stock has gained 4.63%. Precision Biosciences Inc shares have fallen nearly -66.40% since the year began.

DURHAM, N.C.--(BUSINESS WIRE)--Jun. 27, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL) (the “Company”), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced the closing of an underwritten offering of 35,971,224 shares of its common stock at an offering price of $1.39 per share, for total gross proceeds ...INE191C01015. Precision Containeurs Ltd. engages in the manufacture of barrels and trades CRCA coils. It manufactures small, intermediate, and large plastic and metal …Nov 7, 2023 · November 28, 2023. DURHAM, N.C. -- (BUSINESS WIRE)--Nov. 28, 2023-- Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination,... Get the latest Precision BioSciences, Inc. (DTIL) stock news and headlines to help you in your trading and investing decisions.

Precision BioSciences, Inc. Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023 ... Precision BioSciences Receives Approval from The Nasdaq Stock Market LLC to Transfer the Listing of its Common Stock from the Nasdaq Global Select …

Get Our Latest Stock Report on Precision BioSciences. Precision BioSciences Stock Performance. NASDAQ:DTIL traded up $0.01 during trading on Monday, reaching $0.38. The company’s stock had a ...Web

Overall, Precision BioSciences Inc stock has a Value Grade of C, Growth Grade of C, Quality Grade of D, Momentum Grade of F Earnings Estimate Revisions Grade of C. Whether or not you should buy Precision BioSciences Inc stock will ultimately depend on your individual goals, risk tolerance and allocation. AAII can help you figure …Nov 24, 2023 · Precision Biosciences Inc (NASDAQ:DTIL)’s traded shares stood at 0.64 million during the latest session, with the company’s beta value hitting 1.50. At the last check today, the stock’s price was $0.41, to imply a decrease of -3.21% or -$0.01 in intraday trading. The DTIL share’s 52-week ... Precision BioSciences (DTIL Quick Quote DTIL - Free Report) has been on a downward spiral lately with significant selling pressure. After declining 27.5% over the past four weeks, the stock looks ...Discover historical prices for DTIL stock on Yahoo Finance. View daily, weekly or monthly format back to when Precision BioSciences, Inc. stock was issued. May 9, 2023 · Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene ed ... Weighted average shares of common stock ... Precision BioSciences has sold its lead cell therapy asset as the company shifts focus exclusively to gene editing. ... Precision's stock, for instance, closed Monday at $0.45 a share, ...

Get the latest Precision BioSciences Inc (DTIL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …DURHAM, N.C.--(BUSINESS WIRE)--Jul. 27, 2023-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that it has received final meeting minutes from its recent Type B End of Phase 1 meeting with the U.S. Food and Drug Administration (FDA) for its lead ...Currently, the analyst consensus on Precision BioSciences is a Moderate Buy with an average price target of $10.50. See the top stocks recommended by analysts >> DTIL market cap is currently $101 ...Precision BioSciences, Inc. Stock price BOERSE MUENCHEN Equities PBS US74019P1084 Biotechnology & Medical Research Real-time BOERSE MUENCHEN. Other stock markets. 09:13:47 2023-11-21 am EST 5-day change 1st Jan Change ...DTIL Precision Biosciences Inc Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ)DURHAM, N.C.--(BUSINESS WIRE)--Nov. 8, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced financial results for the third quarter ended September 30, 2022 and provided a business update.November 7, 2023 at 4:54 AM · 3 min read. Revenues for Q3 2023 were $13.1 million, a significant increase from $7.4 million in Q3 2022. Net loss for the quarter was $8.1 million, or $ (0.07) per ...

DURHAM, N.C., November 28, 2023--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that, on November 21, 2023, …

Olivier Le Moal. Precision BioSciences ( NASDAQ: DTIL) said it received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) related to a PCSK9-specific ARCUS nuclease. The U.S ...WebNov 22, 2023 · Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for DTIL stock stock is $3.00, which predicts an increase of 607.88%. The lowest target is $2.00 and the highest is $4.00. On average, analysts rate DTIL stock stock as a strong buy. DURHAM, N.C., November 07, 2023 -- ( BUSINESS WIRE )--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in ...NSD:DTIL Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesDec 1, 2023 · A high-level overview of Precision BioSciences, Inc. (DTIL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Operating Status Active; Last Funding Type Post-IPO Equity; Legal Name Precision BioSciences, Inc. Stock Symbol NASDAQ:DTIL; Company Type For Profit. Contact ...We credit much of our successes not only to our technical know-how, but our commitment to our team and our culture. Precision BioSciences utilizes its proprietary ARCUS Genome Editing method to overcome cancers, cure genetic diseases, and enable development of safer food.Nov 20, 2020 · INDIANAPOLIS, and DURHAM, N.C., Nov. 20, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Precision BioSciences, Inc. (Nasdaq: DTIL) today announced a research collaboration and exclusive license agreement to utilize Precision's proprietary ARCUS ® genome editing platform for the research and development of potential in vivo therapies for genetic disorders, with an initial focus on ... Precision BioSciences, Inc. | 18,265 followers on LinkedIn. Dedicated to Improving Life. | Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo ...

On Friday, Precision Biosciences Inc [NASDAQ:DTIL] saw its stock fall -5.64% to $0.40. On the same session, the stock had its day’s lowest price of $0.3853, but rose to a high of $0.44. Over the last five days, the stock has gained 4.63%. Precision Biosciences Inc shares have fallen nearly -66.40% since the year began.

Nov 29, 2023 · The Precision BioSciences Inc. stock price fell by -9.31% on the last day (Wednesday, 29th Nov 2023) from $0.408 to $0.370. During the last trading day the stock fluctuated 15.44% from a day low at $0.360 to a day high of $0.416. The price has risen in 6 of the last 10 days and is up by 6.78% over the past 2 weeks.

Precision BioSciences, Inc. (Nasdaq: ... as an inducement for the employee to commence service with Precision. The stock option has a per share exercise price equal to the fair market value of Precision’s Common Stock on the grant date, which was equal to $0.42. The stock option has a 10-year term and vests …PRECISION BIOSCIENCES, INC. : News, information and stories for PRECISION BIOSCIENCES, INC. | BOERSE MUENCHEN: PBS | BOERSE MUENCHENDTIL | Complete Precision Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.We will never request to mail you a physical check for home office set up or payroll funds. If you are asked for such information, please contact our HR Team by emailing us at [email protected] to verify the legitimacy of the request. Agency recruiters interested in working with us can apply to join our RecruitiFi community.Dozens of bullish and bearish live candlestick chart patterns for the Precision BioSciences Inc stock.Lowe’s is not owned by Walmart or the Walton family. Lowe’s Companies Inc. is a publicly traded company without a majority shareholder. In 2020, The Vanguard Group Inc. held the largest share of Lowe’s stock.Get the latest Precision BioSciences, Inc. (DTIL) stock news and headlines to help you in your trading and investing decisions. Precision BioSciences Completes Spin-Out of Elo Life Systems. December 21, 2021 07:00 AM Eastern Standard Time. DURHAM, N.C.-- ( BUSINESS WIRE )--Precision BioSciences, Inc. (Nasdaq: DTIL), a ...Prometheus Biosciences, Inc. is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and ...Precision Biosciences Inc (NASDAQ:DTIL)’s traded shares stood at 0.64 million during the latest session, with the company’s beta value hitting 1.50. At the last check today, the stock’s price was $0.41, to imply a decrease of -3.21% or -$0.01 in intraday trading. The DTIL share’s 52-week ...H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on Precision BioSciences ( DTIL – Research Report) today and set a price target of $17.00. The company’s shares opened today at ...

Revenue. $115.5 million [1] Number of employees. 192 [2] (2022) Website. precisionbiosciences .com. Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. [3] Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using ...INE191C01015. Precision Containeurs Ltd. engages in the manufacture of barrels and trades CRCA coils. It manufactures small, intermediate, and large plastic and metal …Nov 8, 2023 · Precision BioSciences, Inc. Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023 Nov 15 Precision BioSciences, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Is "Precision Biosciences Inc" a Good Investment? Current price today: △0.424 USD (+1.631%). 7 Days Forecast. Get It Now!Instagram:https://instagram. how to invest in bricswhat does 200 odds meandino sinclairforex brokers for us clients Precision BioSciences, Inc is a clinical-stage gene editing company. It is developing ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and in … list of etfs that pay dividendshow much do you need to trade futures on ninjatrader Investor Relations. IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Our approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient ...Web irish stock brokers Aug 4, 2023 · Precision Biosciences, Inc. Condensed Balance Sheets Data (In thousands, except share amounts) (Unaudited) June 30, 2023: December 31, 2022: Cash and cash equivalents $ 137,794 $ 189,576 Working capital 91,465 139,441 Total assets 181,697 238,169 Total liabilities 147,656 177,736 Total stockholders' equity $ 34,041 $ 60,433 Common stock outstanding Precision BioSciences Inc stock price live 0.2969, this page displays NASDAQ DTIL stock exchange data. View the DTIL premarket stock price ahead of the market session or assess the after hours quote.H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on Precision BioSciences ( DTIL – Research Report) today and set a price target of $17.00. The company’s shares opened today at ...